Mechanisms of apoptosis induced by anticancer compounds in melanoma cells

Andrei L Gartel1

  • 1University of Illinois at Chicago, Department of Medicine, 840, S. Wood St., Room 1041, Chicago, IL 60612, USA. agartel@uic.edu

Insights

Anticancer drugs induce apoptosis in melanoma cells by targeting key proteins and pathways. Understanding these mechanisms, like proteasome inhibition and NF-kB signaling, can improve melanoma treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • In vitro drug sensitivity of cancer cells can predict in vivo response.
  • Human melanoma cells are a focus for studying anticancer drug-induced apoptosis.

Purpose of the Study:

  • To review recent data on anticancer drug-induced apoptosis in human melanoma cells.
  • To explore mechanisms of drug-induced apoptosis for improved melanoma treatment.

Main Methods:

  • Review of existing literature on melanoma cell apoptosis.
  • Analysis of drug mechanisms including proteasome inhibitors, B-Raf, and IKKb inhibitors.
  • Investigation of signaling pathways like FoxM1, Noxa, Mcl-1, and NF-kB.

Main Results:

  • Proteasome inhibitors induce apoptosis in melanoma cells by suppressing FoxM1 and upregulating Noxa.
  • Proteasome inhibitors also affect Mcl-1 stability, influencing apoptosis.
  • Targeting B-Raf or IKKb shows proapoptotic activity dependent on NF-kB inhibition.
  • dsRNA analogs stimulate autophagy and apoptosis, modulated by Noxa.

Conclusions:

  • Mechanisms of drug-induced apoptosis in melanoma involve specific protein and pathway modulation.
  • Understanding these pathways is crucial for developing effective combination therapies for melanoma.
  • Further research into these pathways can guide the design of novel anticancer drug strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...